Stay updated on Anifrolumab SubQ in Lupus Adults Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.

Latest updates to the Anifrolumab SubQ in Lupus Adults Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.5.5 has been added to the history, and the previous revision v3.5.4 has been removed from the visible record, updating the page's revision history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new version on 2026-05-22 includes a Study Status update, and the 2026-04-17 entry was deleted, reflecting changes in the trial's version history.SummaryDifference0.2%

- Check23 days agoChange DetectedThe Record History now shows a new revision label v3.5.4, replacing the previous v3.5.3, indicating a backend deployment update to the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a small platform or display update without changing the underlying study record information.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a Study Status section and updated the page revision to v3.5.2, replacing v3.5.0.SummaryDifference0.3%

- Check80 days agoChange DetectedAdded a 'Study Status' field in the record history and updated to version 44 (2026-03-18) with Revision v3.5.0; the prior entry for v3.4.3 was removed.SummaryDifference0.3%

Stay in the know with updates to Anifrolumab SubQ in Lupus Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.